Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.
2.

Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.

Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM.

Neurology. 1997 Nov;49(5):1219-25.

PMID:
9371897
4.
5.

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.

Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(11):839-51.

PMID:
12921494
6.

Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.

Tuchman M, Hee A, Emeribe U, Silberstein S.

CNS Drugs. 2006;20(12):1019-26.

PMID:
17140280
7.

Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.

Mauskop A, Farkkila M, Hering-Hanit R, Rapoport A, Warner J.

Curr Med Res Opin. 1999;15(4):282-9.

PMID:
10640260
8.

A long-term study to maximise migraine relief with zolmitriptan.

Tepper SJ, Donnan GA, Dowson AJ, Bomhof MA, Elkind A, Meloche J, Fletcher PE, Millson DS.

Curr Med Res Opin. 1999;15(4):254-71.

PMID:
10640258
9.
10.

Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.

Gawel M, Aschoff J, May A, Charlesworth BR; REALIZE Study Team..

Headache. 2005 Jan;45(1):7-16.

PMID:
15663607
11.

A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.

Gallagher RM, Dennish G, Spierings EL, Chitra R.

Headache. 2000 Feb;40(2):119-28.

PMID:
10759911
12.

Oral zolmitriptan is effective in the acute treatment of cluster headache.

Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ.

Neurology. 2000 May 9;54(9):1832-9.

PMID:
10802793
14.

Efficacy of zolmitriptan nasal spray in adolescent migraine.

Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee..

Pediatrics. 2007 Aug;120(2):390-6.

PMID:
17671066
16.

Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.

Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S.

Curr Med Res Opin. 2005 Mar;21(3):381-9.

PMID:
15811207
17.

Zolmitriptan provides consistent migraine relief when used in the long-term.

Tuchman M, Edvinsson L, Geraud G, Korczyn A, Mauskop A, Pfaffenrath V.

Curr Med Res Opin. 1999;15(4):272-81.

PMID:
10640259
18.

Review of zolmitriptan and its clinical applications in migraine.

Dowson AJ, Charlesworth B.

Expert Opin Pharmacother. 2002 Jul;3(7):993-1005. Review.

PMID:
12083998
19.

Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.

Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW.

Headache. 2008 Oct;48(9):1326-36. doi: 10.1111/j.1526-4610.2008.01138.x. Epub 2008 May 14.

PMID:
18484981
20.

Supplemental Content

Support Center